Tapewire

Nasdaq · USD

MCHX

MARCHEX INC

Export transactions ↓
Tapewire entity
6912
SEC CIK
0001224133
Parsed reports
250

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 29, 2022 Filed Nov 30, 2022 21:28 UTC PurchaseClass B Common Stock 125 $1.73 $216.25
Disclosure

SEC source: 0001209191-22-059044 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,754

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 21:17 UTC PurchaseClass B Common Stock 125 $1.75 $218.75
Disclosure

SEC source: 0001209191-22-058644 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,629

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
November 17, 2022 Filed Nov 21, 2022 21:15 UTC PurchaseClass B Common Stock 125 $1.77 $221.13
Disclosure

SEC source: 0001209191-22-058109 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,504

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
November 15, 2022 Filed Nov 16, 2022 21:18 UTC PurchaseClass B Common Stock 125 $1.77 $221.25
Disclosure

SEC source: 0001209191-22-057309 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,379

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:23 UTC PurchaseClass B Common Stock 125 $1.92 $240.60
Disclosure

SEC source: 0001209191-22-056615 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,254

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
September 29, 2022 Filed Oct 3, 2022 20:26 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-22-051833 · doc4.xml · derivative · entry 3

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2032-09-29

F2 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 20:26 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-22-051833 · doc4.xml · nonDerivative · entry 1

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 853,918

F1 · shares: Restricted stock award effective September 29, 2022 (the "Grant Date") with 50% of such shares vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:36 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-22-051848 · doc4.xml · derivative · entry 2

Wisehart Manuel W · CIK 0001440690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2032-09-29

F2 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:36 UTC GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-22-051848 · doc4.xml · nonDerivative · entry 1

Wisehart Manuel W · CIK 0001440690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,145

F1 · shares: Restricted stock award effective September 29, 2022 (the "Grant Date") with 50% of such shares vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:31 UTC
CLINE DENNISDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-22-051840 · doc4.xml · derivative · entry 4

CLINE DENNIS · CIK 0001282220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2032-09-29

F3 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:31 UTC
CLINE DENNISDirector
GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-22-051840 · doc4.xml · nonDerivative · entry 1

CLINE DENNIS · CIK 0001282220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,760

F1 · shares: Restricted stock award effective September 29, 2022 (the "Grant Date") with 50% of such shares vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 20:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-22-051832 · doc4.xml · derivative · entry 2

COGSVILLE DONALD · CIK 0001772911 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2032-09-29

F2 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
September 29, 2022 Filed Oct 3, 2022 20:25 UTC GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-22-051832 · doc4.xml · nonDerivative · entry 1

COGSVILLE DONALD · CIK 0001772911 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,623

F1 · shares: Restricted stock award effective September 29, 2022 (the "Grant Date") with 50% of such shares vesting on September 29, 2023 and September 29, 2024, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
September 08, 2022 Filed Sep 12, 2022 20:22 UTC PurchaseClass B Common Stock 125 $2.07 $258.75
Disclosure

SEC source: 0001209191-22-049495 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,129

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
September 06, 2022 Filed Sep 7, 2022 20:18 UTC PurchaseClass B Common Stock 125 $2.02 $252.50
Disclosure

SEC source: 0001209191-22-049007 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,004

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:29 UTC PurchaseClass B Common Stock 125 $2.07 $258.75
Disclosure

SEC source: 0001209191-22-048747 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,879

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:23 UTC PurchaseClass B Common Stock 125 $2.12 $265.00
Disclosure

SEC source: 0001209191-22-048130 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,754

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
August 25, 2022 Filed Aug 29, 2022 20:19 UTC PurchaseClass B Common Stock 125 $2.17 $271.25
Disclosure

SEC source: 0001209191-22-047850 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,629

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
August 23, 2022 Filed Aug 24, 2022 20:19 UTC PurchaseClass B Common Stock 125 $2.08 $260.00
Disclosure

SEC source: 0001209191-22-047339 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,504

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
August 18, 2022 Filed Aug 22, 2022 20:29 UTC PurchaseClass B Common Stock 125 $2.26 $282.01
Disclosure

SEC source: 0001209191-22-047020 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,379

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:23 UTC PurchaseClass B Common Stock 125 $2.19 $273.75
Disclosure

SEC source: 0001209191-22-046257 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,254

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
June 23, 2022 Filed Jun 23, 2022 20:50 UTC PurchaseClass B Common stock 3,782 $1.25 $4,727.50
Disclosure

SEC source: 0001062993-22-015368 · form4.xml · nonDerivative · entry 3

Edenbrook Capital, LLC · CIK 0001666682 · 10% owner

EDENBROOK LONG ONLY VALUE FUND, LP · CIK 0001665975 · 10% owner

Brolin Jonathan · CIK 0001712127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 13,212,592

F1 · ownership.nature: These securities are held in the account of Edenbrook Long Only Value Fund, LP, a private fund managed by Edenbrook Capital, LLC and may be deemed to be beneficially owned by Edenbrook Capital, LLC by virtue of its role as the investment manger of such private fund. In addition, Jonathan Brolin may be deemed to be a beneficial owner of such securities by virtue of his role as managing member of Edenbrook Capital, LLC.

F3 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:50 UTC PurchaseClass B Common stock 6,514 $1.32 $8,598.48
Disclosure

SEC source: 0001062993-22-015368 · form4.xml · nonDerivative · entry 2

Edenbrook Capital, LLC · CIK 0001666682 · 10% owner

EDENBROOK LONG ONLY VALUE FUND, LP · CIK 0001665975 · 10% owner

Brolin Jonathan · CIK 0001712127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 13,208,810

F1 · ownership.nature: These securities are held in the account of Edenbrook Long Only Value Fund, LP, a private fund managed by Edenbrook Capital, LLC and may be deemed to be beneficially owned by Edenbrook Capital, LLC by virtue of its role as the investment manger of such private fund. In addition, Jonathan Brolin may be deemed to be a beneficial owner of such securities by virtue of his role as managing member of Edenbrook Capital, LLC.

F3 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 20:35 UTC PurchaseClass B Common Stock 125 $1.93 $241.40
Disclosure

SEC source: 0001209191-22-035050 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,129

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
June 02, 2022 Filed Jun 6, 2022 20:33 UTC PurchaseClass B Common Stock 125 $1.97 $246.25
Disclosure

SEC source: 0001209191-22-034530 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192,004

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:45 UTC PurchaseClass B Common Stock 125 $1.94 $242.50
Disclosure

SEC source: 0001209191-22-033184 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,879

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
May 26, 2022 Filed May 31, 2022 20:27 UTC PurchaseClass B Common Stock 125 $1.95 $243.25
Disclosure

SEC source: 0001209191-22-032821 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,754

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
May 24, 2022 Filed May 25, 2022 20:33 UTC PurchaseClass B Common Stock 125 $1.90 $237.50
Disclosure

SEC source: 0001209191-22-031871 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,629

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:26 UTC PurchaseClass B Common Stock 125 $2.20 $275.00
Disclosure

SEC source: 0001209191-22-031318 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,504

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
May 17, 2022 Filed May 18, 2022 20:27 UTC PurchaseClass B Common Stock 125 $2.13 $266.43
Disclosure

SEC source: 0001209191-22-030043 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,379

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a 10b5-1 purchase plan adopted by the reporting person.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:30 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantEmployee Stock Option (right to buy) · Derivative 51,000 $0.00 Strike: $2.56 $0.00
Disclosure

SEC source: 0001209191-22-000294 · doc4.xml · derivative · entry 5

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,000

Underlying: Class B Common Stock · 51,000 shares

Expires 2032-01-03

F5 · derivative.exercise_date: Stock option award effective the Second Grant Date, with 25% of such option shares vesting on the first annual anniversary of the Second Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to double-trigger acceleration upon change of control as set forth in the reporting person's employment agreement with the Issuer.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:30 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantClass B Common Stock 51,000 $0.01 $510.00
Disclosure

SEC source: 0001209191-22-000294 · doc4.xml · nonDerivative · entry 2

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 838,918

F3 · kind: Restricted stock award effective January 3, 2022 (the "Second Grant Date") with 25% of such shares vesting on the first, second, third and fourth annual anniversary of the Second Grant Date, subject to double-trigger acceleration upon change of control as set forth in the reporting person's employment agreement with the Issuer.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 17:33 UTC
Polley RyanChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.56 $0.00
Disclosure

SEC source: 0001209191-22-000297 · doc4.xml · derivative · entry 2

Polley Ryan · CIK 0001804457 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class B Common Stock · 50,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: Stock option award effective on the Grant Date, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Polley remaining a continuous and full-time active employee and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
January 03, 2022 Filed Jan 3, 2022 17:33 UTC
Polley RyanChief Operating Officer
GrantClass B Common Stock 50,000 $0.01 $500.00
Disclosure

SEC source: 0001209191-22-000297 · doc4.xml · nonDerivative · entry 1

Polley Ryan · CIK 0001804457 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,000

F1 · kind: Restricted stock award effective January 3, 2022 (the "Grant Date") with 25% of such shares vesting on the first, second, third and fourth annual anniversary of the Grant Date, subject to Polley remaining a continuous and full-time active employee and with vesting in full of all such shares of restricted stock upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:27 UTC GrantEmployee Stock Option (right to buy) · Derivative 59,000 $0.00 Strike: $2.56 $0.00
Disclosure

SEC source: 0001209191-22-000282 · doc4.xml · derivative · entry 6

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Underlying: Class B Common Stock · 59,000 shares

Expires 2032-01-03

F5 · derivative.exercise_date: Stock option award effective the Second Grant Date, with 25% of such option shares vesting on the first annual anniversary of the Second Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to double-trigger acceleration upon change of control as set forth in the reporting person's employment agreement with the Issuer.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:27 UTC GrantClass B Common Stock 59,000 $0.01 $590.00
Disclosure

SEC source: 0001209191-22-000282 · doc4.xml · nonDerivative · entry 2

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,254

F3 · kind: Restricted stock award effective January 3, 2022 (the "Second Grant Date") with 25% of such shares vesting on the first, second, third and fourth annual anniversary of the Second Grant Date, subject to double-trigger acceleration upon change of control as set forth in the reporting person's employment agreement with the Issuer.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:35 UTC
Roswech JohnChief Revenue Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.56 $0.00
Disclosure

SEC source: 0001209191-22-000301 · doc4.xml · derivative · entry 2

Roswech John · CIK 0001796559 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class B Common Stock · 50,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: Stock option award effective the Grant Date, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Roswech remaining a continuous and full-time active employee.

Read SEC document
January 03, 2022 Filed Jan 3, 2022 22:35 UTC
Roswech JohnChief Revenue Officer
GrantClass B Common Stock 50,000 $0.01 $500.00
Disclosure

SEC source: 0001209191-22-000301 · doc4.xml · nonDerivative · entry 1

Roswech John · CIK 0001796559 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

F1 · kind: Restricted stock award effective January 3, 2022 (the "Grant Date") with 25% of such shares vesting on the first, second, third and forth annual anniversary of the Grant Date, subject to Roswech remaining a continuous and full-time active employee.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 22:30 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantEmployee Stock Option (right to buy) · Derivative 47,500 $0.00 Strike: $2.57 $0.00
Disclosure

SEC source: 0001209191-22-000294 · doc4.xml · derivative · entry 4

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,500

Underlying: Class B Common Stock · 47,500 shares

Expires 2031-12-30

F2 · derivative.exercise_date: See Exhibit A.

F4 · derivative.exercise_date: Option grant effective on the Grant Date.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 22:30 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantClass B Common Stock 47,500 $0.01 $475.00
Disclosure

SEC source: 0001209191-22-000294 · doc4.xml · nonDerivative · entry 1

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 787,918

F1 · kind: Restricted stock award effective December 30, 2021 (the "Grant Date").

F2 · kind: See Exhibit A.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 22:27 UTC GrantEmployee Stock Option (right to buy) · Derivative 98,000 $0.00 Strike: $2.57 $0.00
Disclosure

SEC source: 0001209191-22-000282 · doc4.xml · derivative · entry 5

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,000

Underlying: Class B Common Stock · 98,000 shares

Expires 2031-12-30

F2 · derivative.exercise_date: See Exhibit A.

F4 · derivative.exercise_date: Option grant effective on the Grant Date.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 22:27 UTC GrantClass B Common Stock 98,000 $0.01 $980.00
Disclosure

SEC source: 0001209191-22-000282 · doc4.xml · nonDerivative · entry 1

ARENDS MICHAEL A · CIK 0001282317 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,254

F1 · kind: Restricted stock award effective December 30, 2021 (the "Grant Date").

F2 · kind: See Exhibit A.

Read SEC document
December 02, 2021 Filed Dec 2, 2021 16:21 UTC
CLINE DENNISDirector
OtherClass B Common Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-067570 · doc4.xml · nonDerivative · entry 1

CLINE DENNIS · CIK 0001282220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,760

F1 · kind: The reporting person made a non-cash transfer to a family member for estate planning purposes.

Read SEC document
November 22, 2021 Filed Nov 23, 2021 21:13 UTC PurchaseClass B Common stock 798,714 $2.50 $1,996,785.00
Disclosure

SEC source: 0001062993-21-011470 · form4.xml · nonDerivative · entry 2

Edenbrook Capital, LLC · CIK 0001666682 · 10% owner

EDENBROOK LONG ONLY VALUE FUND, LP · CIK 0001665975 · 10% owner

Brolin Jonathan · CIK 0001712127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 13,202,296

F1 · ownership.nature: These securities are held in the account of Edenbrook Long Only Value Fund, LP, a private fund managed by Edenbrook Capital, LLC and may be deemed to be beneficially owned by Edenbrook Capital, LLC by virtue of its role as the investment manger of such private fund. In addition, Jonathan Brolin may be deemed to be a beneficial owner of such securities by virtue of his role as managing member of Edenbrook Capital, LLC.

F3 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:32 UTC PurchaseClass B Common stock 22,412 $2.75 $61,677.82
Disclosure

SEC source: 0001062993-21-010729 · form4.xml · nonDerivative · entry 2

Edenbrook Capital, LLC · CIK 0001666682 · 10% owner

EDENBROOK LONG ONLY VALUE FUND, LP · CIK 0001665975 · 10% owner

Brolin Jonathan · CIK 0001712127 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 12,403,582

F1 · ownership.nature: These securities are held in the account of Edenbrook Long Only Value Fund, LP, a private fund managed by Edenbrook Capital, LLC and may be deemed to be beneficially owned by Edenbrook Capital, LLC by virtue of its role as the investment manger of such private fund. In addition, Jonathan Brolin may be deemed to be a beneficial owner of such securities by virtue of his role as managing member of Edenbrook Capital, LLC.

F3 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 01, 2021 Filed Oct 4, 2021 20:38 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001209191-21-059007 · doc4.xml · derivative · entry 3

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2031-10-01

F2 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on October 1, 2022 and October 1, 2023, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
October 01, 2021 Filed Oct 4, 2021 20:38 UTC
HOROWITZ RUSSELL CDirector · Executive Chairman · 10% owner · Co-CEO
GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-21-059007 · doc4.xml · nonDerivative · entry 1

HOROWITZ RUSSELL C · CIK 0001054568 · Director · Executive Chairman · 10% owner · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 740,418

F1 · shares: Restricted stock award effective October 1, 2021 (the "Grant Date") with 50% of such shares vesting on October 1, 2022 and October 1, 2023, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
October 01, 2021 Filed Oct 4, 2021 16:45 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001209191-21-059033 · doc4.xml · derivative · entry 2

Wisehart Manuel W · CIK 0001440690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2031-10-01

F2 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on October 1, 2022 and October 1, 2023, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document
October 01, 2021 Filed Oct 4, 2021 16:45 UTC GrantClass B Common Stock 15,000 $0.01 $150.00
Disclosure

SEC source: 0001209191-21-059033 · doc4.xml · nonDerivative · entry 1

Wisehart Manuel W · CIK 0001440690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,145

F1 · shares: Restricted stock award effective October 1, 2021 (the "Grant Date") with 50% of such shares vesting on October 1, 2022 and October 1, 2023, respectively, assuming continued service on the Board for such period and with vesting in full of all such restricted shares upon a Change of Control (as defined in such reporting person's restricted stock agreement).

Read SEC document
October 01, 2021 Filed Oct 4, 2021 16:42 UTC
CLINE DENNISDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001209191-21-059024 · doc4.xml · derivative · entry 4

CLINE DENNIS · CIK 0001282220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class B Common Stock · 20,000 shares

Expires 2031-10-01

F3 · derivative.exercise_date: Option grant effective on the Grant Date with 50% of such options vesting on October 1, 2022 and October 1, 2023, respectively, assuming continued service on the Board for such period and with vesting in full of all such options upon a Change of Control (as defined in such reporting person's option agreement).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.